Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - anpec is indicated for:,-hypertension,-angina of effort,-angina at rest,-vasospastic angina (including prinzmetal?s variant angina),-tachyarrhythmias including paroxysmal supra-ventricular tachycardia,-atrial fibrillation with rapid ventricular response,-atrial flutter with rapid ventricular response

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - verapamil hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - verapamil hydrochloride 40mg;   - film coated tablet - 40 mg - active: verapamil hydrochloride 40mg   excipient: acacia calcium carbonate carmellose sodium colloidal silicon dioxide   glycol montanate calcium arachinate lactose monohydrate maize starch   potato starch povidone purified talc   purified water quinoline yellow sucrose titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - verapamil hydrochloride 80mg;   - film coated tablet - 80 mg - active: verapamil hydrochloride 80mg   excipient: acacia calcium carbonate carmellose sodium colloidal silicon dioxide gelatin glycol montanate lactose monohydrate magnesium stearate maize starch   microcrystalline cellulose potato starch povidone purified talc   quinoline yellow sucrose titanium dioxide

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - indications as at 17 jan 2005 : tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.,tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - verapamil hydrochloride -

Egypt - English - EDA (Egyptian Drug Authority)

abbott laboratories-germany - sustained release tablets - 240 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

20 's(10's blister x 2) -

Canada - English - Health Canada

apotex inc - verapamil hydrochloride - tablet - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 180mg - verapamil hydrochloride 180mg - miscellaneous calcium-channel blocking agents